Source: Annual Congress 2002 - Respiratory and skeletal muscle
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. S. Hopkinson, S. Genth-Zotz, A. Krack, S. D. Anker, M. I. Polkey (London, United Kingdom). Increased TNFα production in whole blood is associated with disease severity in COPD. Eur Respir J 2002; 20: Suppl. 38, 3113

Member's Comments

No comment yet.

Related content which might interest you: Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Increased risk of peripheral arterial disease in individuals with COPD Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Comorbidities in COPD patients are not associated to higher disease severity Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Relationship between blood eosinophil levels and severity of COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Are COPD exacerbations associated with the severity of the disease? Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005 Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004 Content of adiponectin in blood of COPD patients depending on stage of disease and presence of emphysema Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017 Year: 2017 Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease. Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021